INAB
In8bio Inc
NASDAQ: INAB · HEALTHCARE · BIOTECHNOLOGY
$1.47
-2.65% today
Updated 2026-04-30
Market cap
$15.36M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.44
Dividend yield
—
52W range
$1 – $6
Volume
0.1M
In8bio Inc (INAB) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-92.50%
ROA
-46.60%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $0.00 | $-2.08M | — | — | — |
| 2019 | $0.00 | $-5.13M | — | — | — |
| 2020 | $0.00 | $-8.56M | — | — | — |
| 2021 | $0.00 | $-14.65M | — | — | — |
| 2022 | $0.00 | $-27.42M | — | — | — |
| 2023 | $0.00 | $-30.01M | — | — | — |
| 2024 | $0.00 | $-30.44M | — | — | — |
| 2025 | $0.00 | $-19.44M | — | — | — |